Chemoprevention for prostate cancer
- 1 April 1995
- Vol. 75 (S7) , 1783-1789
- https://doi.org/10.1002/1097-0142(19950401)75:7+<1783::aid-cncr2820751606>3.0.co;2-u
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasiaThe Prostate, 1993
- Effects of 6-methylene progesterone on growth, morphology, and blood flow of the dunning R3327 prostatic adenocarcinomaThe Prostate, 1992
- Significance of prosttic intraepithelial neoplasia on prostate needle biopsyUrology, 1991
- Tolerability of the synthetic retinoid fenretinide® (HPR)European Journal of Cancer and Clinical Oncology, 1989
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- The role of diet in prostate cancerNutrition and Cancer, 1987
- Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of the ODC inhibitor alpha-difluoromethylornithineThe Prostate, 1982
- Role of Polyamines in the Control of Cell Proliferation and DifferentiationDifferentiation, 1981
- Effect of α-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissuesLife Sciences, 1979
- Diet as an etiological factor in the development of cancers of the colon and rectumJournal of Chronic Diseases, 1975